Interplay between the SAFE and the sphingolipid pathway for cardioprotection.
Saved in:
| Title: | Interplay between the SAFE and the sphingolipid pathway for cardioprotection. |
|---|---|
| Authors: | Cour M; Hatter Institute/Cape Heart Institute, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Pedretti S; Hatter Institute/Cape Heart Institute, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Nduhirabandi F; Hatter Institute/Cape Heart Institute, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Hacking D; Hatter Institute/Cape Heart Institute, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Frias MA; Division of Laboratory Medicine, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland., Hausenloy DJ; The Hatter Cardiovascular Institute, University College London, London, UK., Lecour S; Hatter Institute/Cape Heart Institute, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Electronic address: Sandrine.lecour@uct.ac.za. |
| Source: | Life sciences [Life Sci] 2024 Dec 01; Vol. 358, pp. 123145. Date of Electronic Publication: 2024 Oct 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0631 (Electronic) Linking ISSN: 00243205 NLM ISO Abbreviation: Life Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
